论文部分内容阅读
目的:探讨中医望小儿食指络脉与新生儿窒息Apgar评分的相关性。方法:选择2011年9月—2013年9月出生的新生儿1024例作为观察对象,根据Apgar评分结果将上述新生儿分为正常组683例(Apgar评分≥8分)以及窒息组341例(Apgar评分≤7分),观察两组新生儿是指脉络的表里、颜色和三关情况,并进行比较分析。结果:正常组脉络位于风关627例(91.80%)、气关56例(8.20%)、命关0例,窒息组位于风关26例(7.62%)、气关282例(82.70%)、命关33例(9.68%),两组比较,差异具有统计学意义(P<0.05);正常组食指脉络颜色淡红561例(82.14%)、鲜红84例(12.30%)、紫38例(5.56%);窒息组食指脉络颜色淡红22例(6.54%)、鲜红194例(56.89%)、紫125例(36.66%),两组比较,差异具有统计学意义(P<0.05);正常组食指脉络浮109例(15.96%)、不浮不沉422例(61.79%)、沉152例(22.25%);窒息组食指脉络浮、164例(48.09%)不浮不沉83例(24.34%)、沉94例(27.57%),两组比较,差异具有统计学意义(P<0.05)。结论:望小儿指纹,能达到“三关辨轻重”的诊断要求,可用于新生儿窒息Apgar评分的辅助诊断,值得临床推广。
Objective: To investigate the relationship between apoplectic index finger collaterals and neonatal asphyxia Apgar score in Chinese medicine. Methods: A total of 1024 neonates born from September 2011 to September 2013 were selected as the observation subjects. According to Apgar score, 683 newborns (Apgar score ≥8) and 341 asphyxia groups (Apgar Score ≤ 7 points), observed two groups of newborns refers to the context of the veins, color and the third off, and comparative analysis. Results: There were 627 cases (91.80%) in normal group, 56 cases (8.20%) in critical condition, 0 cases in vital concern group, 26 cases (7.62%) in critical condition group and 282 cases (82.70% (P <0.05). There were 561 cases (82.14%), 84 cases (12.30%) of bright red and 38 cases of purple (P <0.05) in the normal group 5.56%). In the asphyxia group, 22 cases (6.54%) had reddish color of the index finger vein, 194 cases (56.89%) were bright red and 125 cases (36.66%) were purple. There were significant differences between the two groups In the asphyxia group, there were 109 (15.96%) cases of floating of the index finger, 422 cases (61.79%) floating without sinking and 152 cases (22.25% %), Shen 94 cases (27.57%), the difference between the two groups was statistically significant (P <0.05). Conclusion: The pediatric fingerprints can meet the diagnostic requirements of “three levels of discrimination,” which can be used for the diagnosis of neonatal apgar apgar score, worthy of clinical promotion.